Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder.

Kennedy SH, Avedisova A, Giménez-Montesinos N, Belaïdi C, de Bodinat C; Agomelatine Study Group.

Eur Neuropsychopharmacol. 2014 Apr;24(4):553-63. doi: 10.1016/j.euroneuro.2014.01.006. Epub 2014 Jan 31.

PMID:
24530273
2.

Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis.

Riecher-Rössler A, Rybakowski JK, Pflueger MO, Beyrau R, Kahn RS, Malik P, Fleischhacker WW; EUFEST Study Group.

Psychol Med. 2013 Dec;43(12):2571-82. doi: 10.1017/S0033291713000226. Epub 2013 Apr 17.

PMID:
23590895
3.

Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).

Weisler RH, Nolen WA, Neijber A, Hellqvist A, Paulsson B; Trial 144 Study Investigators.

J Clin Psychiatry. 2011 Nov;72(11):1452-64. doi: 10.4088/JCP.11m06878. Erratum in: J Clin Psychiatry. 2014 Mar;75(3):290.

PMID:
22054050
4.

Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study.

Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW; EUFEST group.

Schizophr Res. 2009 Dec;115(2-3):104-14. doi: 10.1016/j.schres.2009.09.022. Epub 2009 Oct 12.

PMID:
19822407
5.

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Grobbee DE; EUFEST study group.

Lancet. 2008 Mar 29;371(9618):1085-97. doi: 10.1016/S0140-6736(08)60486-9.

PMID:
18374841
6.

Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.

Möller HJ, Johnson S, Mateva T, Brecher M, Svensson O, Miller F, Meulien D; Study 146 Investigators.

Int Clin Psychopharmacol. 2008 Mar;23(2):95-105. doi: 10.1097/YIC.0b013e3282f2d42c.

PMID:
18301124
Items per page

Supplemental Content

Loading ...
Write to the Help Desk